Global Retinal Biosimilars Market Growth (Status and Outlook) 2022-2028
- LP 4844561
- 103 Pages
- February 2022
- Medical Devices
The United States Retinal Biosimilars market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Retinal Biosimilars market, reaching US$ million by the year 2028. As for the Europe Retinal Biosimilars landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Retinal Biosimilars players cover Novartis (Sandoz), Takeda, Bayer, and Genentech, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Retinal Biosimilars market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Macular Degeneration Drugs
Diabetic Eye Disease Drugs
Macular Pucker Drugs
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Novartis (Sandoz)
Takeda
Bayer
Genentech
Pfenex
Reliance Life Sciences
Hetero Drugs
Intas Pharmaceuticals
Santo Holding
Regeneron Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Retinal Biosimilars Market Size 2017-2028
2.1.2 Retinal Biosimilars Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Retinal Biosimilars Segment by Type
2.2.1 Macular Degeneration Drugs
2.2.2 Diabetic Eye Disease Drugs
2.2.3 Macular Pucker Drugs
2.2.4 Others
2.3 Retinal Biosimilars Market Size by Type
2.3.1 Retinal Biosimilars Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Retinal Biosimilars Market Size Market Share by Type (2017-2022)
2.4 Retinal Biosimilars Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Retinal Biosimilars Market Size by Application
2.5.1 Retinal Biosimilars Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Retinal Biosimilars Market Size Market Share by Application (2017-2022)
3 Retinal Biosimilars Market Size by Player
3.1 Retinal Biosimilars Market Size Market Share by Players
3.1.1 Global Retinal Biosimilars Revenue by Players (2020-2022)
3.1.2 Global Retinal Biosimilars Revenue Market Share by Players (2020-2022)
3.2 Global Retinal Biosimilars Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Retinal Biosimilars by Regions
4.1 Retinal Biosimilars Market Size by Regions (2017-2022)
4.2 Americas Retinal Biosimilars Market Size Growth (2017-2022)
4.3 APAC Retinal Biosimilars Market Size Growth (2017-2022)
4.4 Europe Retinal Biosimilars Market Size Growth (2017-2022)
4.5 Middle East & Africa Retinal Biosimilars Market Size Growth (2017-2022)
5 Americas
5.1 Americas Retinal Biosimilars Market Size by Country (2017-2022)
5.2 Americas Retinal Biosimilars Market Size by Type (2017-2022)
5.3 Americas Retinal Biosimilars Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Retinal Biosimilars Market Size by Region (2017-2022)
6.2 APAC Retinal Biosimilars Market Size by Type (2017-2022)
6.3 APAC Retinal Biosimilars Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Retinal Biosimilars by Country (2017-2022)
7.2 Europe Retinal Biosimilars Market Size by Type (2017-2022)
7.3 Europe Retinal Biosimilars Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Retinal Biosimilars by Region (2017-2022)
8.2 Middle East & Africa Retinal Biosimilars Market Size by Type (2017-2022)
8.3 Middle East & Africa Retinal Biosimilars Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Retinal Biosimilars Market Forecast
10.1 Global Retinal Biosimilars Forecast by Regions (2023-2028)
10.1.1 Global Retinal Biosimilars Forecast by Regions (2023-2028)
10.1.2 Americas Retinal Biosimilars Forecast
10.1.3 APAC Retinal Biosimilars Forecast
10.1.4 Europe Retinal Biosimilars Forecast
10.1.5 Middle East & Africa Retinal Biosimilars Forecast
10.2 Americas Retinal Biosimilars Forecast by Country (2023-2028)
10.2.1 United States Retinal Biosimilars Market Forecast
10.2.2 Canada Retinal Biosimilars Market Forecast
10.2.3 Mexico Retinal Biosimilars Market Forecast
10.2.4 Brazil Retinal Biosimilars Market Forecast
10.3 APAC Retinal Biosimilars Forecast by Region (2023-2028)
10.3.1 China Retinal Biosimilars Market Forecast
10.3.2 Japan Retinal Biosimilars Market Forecast
10.3.3 Korea Retinal Biosimilars Market Forecast
10.3.4 Southeast Asia Retinal Biosimilars Market Forecast
10.3.5 India Retinal Biosimilars Market Forecast
10.3.6 Australia Retinal Biosimilars Market Forecast
10.4 Europe Retinal Biosimilars Forecast by Country (2023-2028)
10.4.1 Germany Retinal Biosimilars Market Forecast
10.4.2 France Retinal Biosimilars Market Forecast
10.4.3 UK Retinal Biosimilars Market Forecast
10.4.4 Italy Retinal Biosimilars Market Forecast
10.4.5 Russia Retinal Biosimilars Market Forecast
10.5 Middle East & Africa Retinal Biosimilars Forecast by Region (2023-2028)
10.5.1 Egypt Retinal Biosimilars Market Forecast
10.5.2 South Africa Retinal Biosimilars Market Forecast
10.5.3 Israel Retinal Biosimilars Market Forecast
10.5.4 Turkey Retinal Biosimilars Market Forecast
10.5.5 GCC Countries Retinal Biosimilars Market Forecast
10.6 Global Retinal Biosimilars Forecast by Type (2023-2028)
10.7 Global Retinal Biosimilars Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Novartis (Sandoz)
11.1.1 Novartis (Sandoz) Company Information
11.1.2 Novartis (Sandoz) Retinal Biosimilars Product Offered
11.1.3 Novartis (Sandoz) Retinal Biosimilars Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Novartis (Sandoz) Main Business Overview
11.1.5 Novartis (Sandoz) Latest Developments
11.2 Takeda
11.2.1 Takeda Company Information
11.2.2 Takeda Retinal Biosimilars Product Offered
11.2.3 Takeda Retinal Biosimilars Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Takeda Main Business Overview
11.2.5 Takeda Latest Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Retinal Biosimilars Product Offered
11.3.3 Bayer Retinal Biosimilars Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Bayer Main Business Overview
11.3.5 Bayer Latest Developments
11.4 Genentech
11.4.1 Genentech Company Information
11.4.2 Genentech Retinal Biosimilars Product Offered
11.4.3 Genentech Retinal Biosimilars Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Genentech Main Business Overview
11.4.5 Genentech Latest Developments
11.5 Pfenex
11.5.1 Pfenex Company Information
11.5.2 Pfenex Retinal Biosimilars Product Offered
11.5.3 Pfenex Retinal Biosimilars Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Pfenex Main Business Overview
11.5.5 Pfenex Latest Developments
11.6 Reliance Life Sciences
11.6.1 Reliance Life Sciences Company Information
11.6.2 Reliance Life Sciences Retinal Biosimilars Product Offered
11.6.3 Reliance Life Sciences Retinal Biosimilars Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Reliance Life Sciences Main Business Overview
11.6.5 Reliance Life Sciences Latest Developments
11.7 Hetero Drugs
11.7.1 Hetero Drugs Company Information
11.7.2 Hetero Drugs Retinal Biosimilars Product Offered
11.7.3 Hetero Drugs Retinal Biosimilars Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Hetero Drugs Main Business Overview
11.7.5 Hetero Drugs Latest Developments
11.8 Intas Pharmaceuticals
11.8.1 Intas Pharmaceuticals Company Information
11.8.2 Intas Pharmaceuticals Retinal Biosimilars Product Offered
11.8.3 Intas Pharmaceuticals Retinal Biosimilars Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Intas Pharmaceuticals Main Business Overview
11.8.5 Intas Pharmaceuticals Latest Developments
11.9 Santo Holding
11.9.1 Santo Holding Company Information
11.9.2 Santo Holding Retinal Biosimilars Product Offered
11.9.3 Santo Holding Retinal Biosimilars Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Santo Holding Main Business Overview
11.9.5 Santo Holding Latest Developments
11.10 Regeneron Pharmaceuticals
11.10.1 Regeneron Pharmaceuticals Company Information
11.10.2 Regeneron Pharmaceuticals Retinal Biosimilars Product Offered
11.10.3 Regeneron Pharmaceuticals Retinal Biosimilars Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Regeneron Pharmaceuticals Main Business Overview
11.10.5 Regeneron Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
Table 1. Retinal Biosimilars Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Macular Degeneration Drugs
Table 3. Major Players of Diabetic Eye Disease Drugs
Table 4. Major Players of Macular Pucker Drugs
Table 5. Major Players of Others
Table 6. Retinal Biosimilars Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Retinal Biosimilars Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Retinal Biosimilars Market Size Market Share by Type (2017-2022)
Table 9. Retinal Biosimilars Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Retinal Biosimilars Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Retinal Biosimilars Market Size Market Share by Application (2017-2022)
Table 12. Global Retinal Biosimilars Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Retinal Biosimilars Revenue Market Share by Player (2020-2022)
Table 14. Retinal Biosimilars Key Players Head office and Products Offered
Table 15. Retinal Biosimilars Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Retinal Biosimilars Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Retinal Biosimilars Market Size Market Share by Regions (2017-2022)
Table 20. Americas Retinal Biosimilars Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Retinal Biosimilars Market Size Market Share by Country (2017-2022)
Table 22. Americas Retinal Biosimilars Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Retinal Biosimilars Market Size Market Share by Type (2017-2022)
Table 24. Americas Retinal Biosimilars Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Retinal Biosimilars Market Size Market Share by Application (2017-2022)
Table 26. APAC Retinal Biosimilars Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Retinal Biosimilars Market Size Market Share by Region (2017-2022)
Table 28. APAC Retinal Biosimilars Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Retinal Biosimilars Market Size Market Share by Type (2017-2022)
Table 30. APAC Retinal Biosimilars Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Retinal Biosimilars Market Size Market Share by Application (2017-2022)
Table 32. Europe Retinal Biosimilars Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Retinal Biosimilars Market Size Market Share by Country (2017-2022)
Table 34. Europe Retinal Biosimilars Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Retinal Biosimilars Market Size Market Share by Type (2017-2022)
Table 36. Europe Retinal Biosimilars Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Retinal Biosimilars Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Retinal Biosimilars Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Retinal Biosimilars Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Retinal Biosimilars Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Retinal Biosimilars Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Retinal Biosimilars Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Retinal Biosimilars Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Retinal Biosimilars
Table 45. Key Market Challenges & Risks of Retinal Biosimilars
Table 46. Key Industry Trends of Retinal Biosimilars
Table 47. Global Retinal Biosimilars Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Retinal Biosimilars Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Retinal Biosimilars Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Retinal Biosimilars Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Retinal Biosimilars Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Retinal Biosimilars Market Size Market Share Forecast by Application (2023-2028)
Table 53. Novartis (Sandoz) Details, Company Type, Retinal Biosimilars Area Served and Its Competitors
Table 54. Novartis (Sandoz) Retinal Biosimilars Product Offered
Table 55. Novartis (Sandoz) Retinal Biosimilars Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Novartis (Sandoz) Main Business
Table 57. Novartis (Sandoz) Latest Developments
Table 58. Takeda Details, Company Type, Retinal Biosimilars Area Served and Its Competitors
Table 59. Takeda Retinal Biosimilars Product Offered
Table 60. Takeda Main Business
Table 61. Takeda Retinal Biosimilars Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Takeda Latest Developments
Table 63. Bayer Details, Company Type, Retinal Biosimilars Area Served and Its Competitors
Table 64. Bayer Retinal Biosimilars Product Offered
Table 65. Bayer Main Business
Table 66. Bayer Retinal Biosimilars Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Bayer Latest Developments
Table 68. Genentech Details, Company Type, Retinal Biosimilars Area Served and Its Competitors
Table 69. Genentech Retinal Biosimilars Product Offered
Table 70. Genentech Main Business
Table 71. Genentech Retinal Biosimilars Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Genentech Latest Developments
Table 73. Pfenex Details, Company Type, Retinal Biosimilars Area Served and Its Competitors
Table 74. Pfenex Retinal Biosimilars Product Offered
Table 75. Pfenex Main Business
Table 76. Pfenex Retinal Biosimilars Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Pfenex Latest Developments
Table 78. Reliance Life Sciences Details, Company Type, Retinal Biosimilars Area Served and Its Competitors
Table 79. Reliance Life Sciences Retinal Biosimilars Product Offered
Table 80. Reliance Life Sciences Main Business
Table 81. Reliance Life Sciences Retinal Biosimilars Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Reliance Life Sciences Latest Developments
Table 83. Hetero Drugs Details, Company Type, Retinal Biosimilars Area Served and Its Competitors
Table 84. Hetero Drugs Retinal Biosimilars Product Offered
Table 85. Hetero Drugs Main Business
Table 86. Hetero Drugs Retinal Biosimilars Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Hetero Drugs Latest Developments
Table 88. Intas Pharmaceuticals Details, Company Type, Retinal Biosimilars Area Served and Its Competitors
Table 89. Intas Pharmaceuticals Retinal Biosimilars Product Offered
Table 90. Intas Pharmaceuticals Main Business
Table 91. Intas Pharmaceuticals Retinal Biosimilars Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Intas Pharmaceuticals Latest Developments
Table 93. Santo Holding Details, Company Type, Retinal Biosimilars Area Served and Its Competitors
Table 94. Santo Holding Retinal Biosimilars Product Offered
Table 95. Santo Holding Main Business
Table 96. Santo Holding Retinal Biosimilars Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Santo Holding Latest Developments
Table 98. Regeneron Pharmaceuticals Details, Company Type, Retinal Biosimilars Area Served and Its Competitors
Table 99. Regeneron Pharmaceuticals Retinal Biosimilars Product Offered
Table 100. Regeneron Pharmaceuticals Main Business
Table 101. Regeneron Pharmaceuticals Retinal Biosimilars Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. Regeneron Pharmaceuticals Latest Developments
List of Figures
Figure 1. Retinal Biosimilars Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Retinal Biosimilars Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Retinal Biosimilars Market Size Market Share by Type in 2021
Figure 7. Retinal Biosimilars in Hospital Pharmacies
Figure 8. Global Retinal Biosimilars Market: Hospital Pharmacies (2017-2022) & ($ Millions)
Figure 9. Retinal Biosimilars in Retail Pharmacies
Figure 10. Global Retinal Biosimilars Market: Retail Pharmacies (2017-2022) & ($ Millions)
Figure 11. Retinal Biosimilars in Online Pharmacies
Figure 12. Global Retinal Biosimilars Market: Online Pharmacies (2017-2022) & ($ Millions)
Figure 13. Global Retinal Biosimilars Market Size Market Share by Application in 2021
Figure 14. Global Retinal Biosimilars Revenue Market Share by Player in 2021
Figure 15. Global Retinal Biosimilars Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Retinal Biosimilars Market Size 2017-2022 ($ Millions)
Figure 17. APAC Retinal Biosimilars Market Size 2017-2022 ($ Millions)
Figure 18. Europe Retinal Biosimilars Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Retinal Biosimilars Market Size 2017-2022 ($ Millions)
Figure 20. Americas Retinal Biosimilars Value Market Share by Country in 2021
Figure 21. Americas Retinal Biosimilars Consumption Market Share by Type in 2021
Figure 22. Americas Retinal Biosimilars Market Size Market Share by Application in 2021
Figure 23. United States Retinal Biosimilars Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Retinal Biosimilars Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Retinal Biosimilars Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Retinal Biosimilars Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Retinal Biosimilars Market Size Market Share by Region in 2021
Figure 28. APAC Retinal Biosimilars Market Size Market Share by Application in 2021
Figure 29. China Retinal Biosimilars Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Retinal Biosimilars Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Retinal Biosimilars Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Retinal Biosimilars Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Retinal Biosimilars Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Retinal Biosimilars Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Retinal Biosimilars Market Size Market Share by Country in 2021
Figure 36. Europe Retinal Biosimilars Market Size Market Share by Type in 2021
Figure 37. Europe Retinal Biosimilars Market Size Market Share by Application in 2021
Figure 38. Germany Retinal Biosimilars Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Retinal Biosimilars Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Retinal Biosimilars Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Retinal Biosimilars Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Retinal Biosimilars Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Retinal Biosimilars Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Retinal Biosimilars Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Retinal Biosimilars Market Size Market Share by Application in 2021
Figure 46. Egypt Retinal Biosimilars Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Retinal Biosimilars Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Retinal Biosimilars Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Retinal Biosimilars Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Retinal Biosimilars Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 52. APAC Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 53. Europe Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 55. United States Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 56. Canada Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 59. China Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 60. Japan Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 61. Korea Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 63. India Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 64. Australia Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 65. Germany Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 66. France Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 67. UK Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 68. Italy Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 69. Russia Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 70. Spain Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 73. Israel Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Retinal Biosimilars Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
